Advertisement

Topics

Latest Biotechnology, Pharmaceutical and Healthcare News from Businesswire

06:06 EST 12th December 2018 | BioPortfolio

Here are the most relevant search results for "Businesswire" found in our extensive news archives from over 250 global news sources.

More Information about Businesswire on BioPortfolio

In addition to our news stories we have dozens of PubMed Articles about Businesswire for you to read. Along with our medical data and news we also list Businesswire Clinical Trials, which are updated daily. BioPortfolio also has a large database of Businesswire Companies for you to search.

Showing News Articles 1–25 of 20,000+ from Businesswire

Wednesday 12th December 2018

Rodin Therapeutics Announces Initiation of Phase 1 Clinical Trial of a Selective CoREST Inhibitor to Treat Neurologic Diseases

Rodin Therapeutics today announced the initiation of a Phase 1 clinical trial of the company’s lead candidate, RDN-929, a potent and selective HDAC-CoREST inhibitor. The compound is designed to treat synaptopathies, a group of over 100 brain diseases characterized by synaptic loss and dysfunction. The randomized, double-blind, placebo-con...

PatientPop Publishes Comprehensive Practice Growth Playbook

Healthcare providers can use the playbook to master local search marketing and get found online. PatientPop, the market leader in practice growth technology, has released the

InterVenn BioSciences Raises $9.4 Million to Help Physicians Detect Early Ovarian Cancer With a Minimally Invasive Test

Funding to accelerate InterVenn’s development of its AI-driven mass spectrometry platform that measures glycoproteomic markers that have been strongly linked to tumor development and progression. InterVenn BioSciences, a life sciences and technology company developing an AI-driven mass spectrometry platform, announced today an institutional investmen...

Juniper Research: Hearables to Revolutionise Personal Audio With Over 50% of all Wireless Headphones Incorporating Hearable Tech by 2022

Voice assistants, touch sensors and other interface technologies will become the new standard for personal audio in under 5 years. A new report from Juniper Research has found that there will be an estimated 417 million hearables in use by 2022. This includes fitness-focused devices, hearing augmentation and purely audio-focused devices. ...

First production and administration of Axumin▼® (fluciclovine (18F)) in France.

Blue Earth Diagnostics, a leading molecular imaging diagnostics company, today announced that the first commercial production of Axumin® (fluciclovine (18F)) in France occurred recently, with the first French patients being dosed. Axumin is a novel molecular imaging agent approved in the European Union for use in PET imaging to detect and localize ...

Libertex Trading Platform Adds 5 CFDs on Cannabis Stocks

Libertex has added five new contracts for difference (CFDs) to its trading platform. Starting from December 11th, 2018, traders using our cross-channel platform will be able to trade with the five hottest instruments, which represent the world’s most popular companies operating in the growing sphere of marijuana production and processing. ...

GenSight Biologics Reports Sustained Quality of Life Improvements at Week 72 of Phase III REVERSE Clinical Trial of GS010 for the Treatment of Leber Hereditary Optic Neuropathy (LHON)

Composite score and relevant sub-scores in the National Eye Institute Visual Function Questionnaire-25 (NEI VFQ-25) showed sustained improvements at Week 48 and Week 72 Magnitudes of score improvement observed with GS010 correlate with clinically meaningful improvements in best-corrected visual acuity (BCVA) ...

Patrick Treanor appointed President of Relypsa and member of the Executive Committee of Vifor Pharma Group

Regulatory News: This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20181211005987/en/ Vifor Pharma Group is pleased to announce the appointment of Patrick Treanor as President of Relypsa on a permanent basis. He is also appointed to the Executive Committee of Vifor Pharma Group with immediate e...

Tuesday 11th December 2018

Dr. John Houston of Arvinas Named 2018 BioCT Entrepreneur of the Year

In a ceremony December 11 at the BioCT Annual Bioscience Holiday Celebration & Networking Party in New Haven, the 2018 BioCT Entrepreneur of the Year award was presented to Dr. John Houston of Arvinas, a biotechnology executive whose work has positively affected bioscience in Connecticut and beyond. Dr. Houston is President and CEO of Arvinas,...

California Life Sciences Association (CLSA) Welcomes Proposed 5-Year Delay of Medical Device Tax

Year-end bill introduced in lame duck session recommends extending delays on certain taxes, including a 5-year moratorium on 2.3% medical device tax until December 2024 California Life Sciences Association (CLSA), the trade association representing California’s life sciences industry, welcomes the introduction of

SEIU 775 Benefits Group Partners with SR Max Slip Resistant Shoes to Launch Caregiver Kicks

25,000 slip resistant shoes to be distributed to caregivers throughout Washington State SEIU 775 Benefits Group, the nation’s leading organization dedicated to improving the skills, health, and sustainability of the home care workforce, is partnering with SR Max Slip Resistant Shoes in order to offer slip resistant footwear to caregivers at no cost t...

Reliant Bank Earns Top Fundraising Honors with Donation to Leukemia and Lymphoma Society

Bank Doubles Donation from Prior Year during Costumed for a Cure Contest Reliant Bank announced a donation of more than $4,000 to the Leukemia and Lymphoma Society. In its second year participating in the Costumed for a Cure fundraiser, the bank placed first in overall funding in Tennessee and doubled their contribution amount raised in the prior year....

Rite Aid to Release Third Quarter Results on December 19

Rite Aid Corporation (NYSE: RAD) said today that it will release financial results for its Fiscal 2019 Third Quarter, which ended Dec. 1, 2018, on Wednesday, Dec. 19, 2018. The company will hold an analyst call at 5:00 p.m. Eastern Time with remarks by Rite Aid's management team. The call will be broadcast via the Internet at https://www.riteaid.com/corporate/inv...

Walgreens Boots Alliance Announces Transfer of Listing of Debt Securities to Nasdaq

Walgreens Boots Alliance, Inc. (Nasdaq: WBA) today announced it will be transferring the securities exchange listing for its 2.125% Senior Notes due 2026, 2.875% Senior Notes due 2020 and 3.600% Senior Notes due 2025 from the New York Stock Exchange to the Nasdaq Bond Exchange effective December 21, 2018 after market close. The debt securities are expected ...

Glaukos iStent inject® Implantation with Concomitant Cataract Surgery Provides Sustained Reduction in IOP and Medication Burden, According to New Study

Three-Year Outcomes Reveal 37% Mean IOP Decline to 14.3 mmHg, 68% Decline in Mean Number of Topical Ocular Hypotensive Medications and Favorable Safety Profile Glaukos Corporation (NYSE: GKOS), an ophthalmic medical technology and pharmaceutical company focused on the development and commercialization of novel surgical devices and sustained pharmaceuti...

Model N Welcomes New Senior Leadership and a New Board Member

New executive leadership to help Model N’s enterprise SaaS business grow and scale Model N, Inc. (NYSE: MODN), the leading provider of cloud revenue management solutions to pharmaceutical, medical device, high-tech manufacturing, and semiconductor companies, today announced new additions to its Board of Directors and leadership team. ...

Global Medical REIT Inc. Commences Common Stock Public Offering

Global Medical REIT Inc. (NYSE:GMRE) (the “Company”) today commenced an underwritten public offering (the “offering”) of its common stock, par value $0.001 per share, subject to market and other conditions. The Company expects to grant the underwriters a 30-day option to purchase an additional 15% of the shares of common stock being offered in the ...

Intersect ENT to Present at the 37th Annual J.P. Morgan Healthcare Conference

Intersect ENT, Inc. (Nasdaq: XENT), today announced that management will participate in the 37th Annual J.P. Morgan Healthcare Conference on Tuesday, January 8, 2019 at the Westin St. Francis Hotel in San Francisco, and will present at 4:30 p.m. PT. A replay of the session will be available via the investors section of the company’s websi...

Five Star Senior Living Inc. Announces the Appointment of Katie Potter as President and Chief Executive Officer Effective January 1, 2019

Current President and Chief Executive Officer, Bruce Mackey, is Retiring Five Star Senior Living Inc. (Nasdaq: FVE) today announced that Katherine E. Potter, age 42, has been appointed as President and Chief Executive Officer, effective January 1, 2019. Ms. Potter has been with Five Star since 2012 and currently serves as Executive Vice...

Axonics® Announces Third Quarter 2018 Financial Results and Operational Update

Axonics Modulation Technologies, Inc. (NASDAQ: AXNX) a medical technology company focused on the development and commercialization of novel implantable Sacral Neuromodulation (“SNM”) devices for the treatment of urinary and bowel dysfunction, reported today financial results for the quarter ended September 30, 2018 and provided an u...

Arrowhead Pharmaceuticals Reports Fiscal 2018 Year End Results

Conference Call and Webcast Today at 4:30 p.m. EST Arrowhead Pharmaceuticals Inc. (NASDAQ: ARWR) today announced financial results for its fiscal 2018 fourth quarter and year ended September 30, 2018. The company is hosting a conference call at 4:30 p.m. EST to discuss results. Conference Call and Webcast Details Investors may ...

Tenax Therapeutics Announces Closing of $10 Million Underwritten Offering

Tenax Therapeutics, Inc. (Nasdaq: TENX) (“Tenax” or the “Company”), a specialty pharmaceutical company focused on identifying, developing and commercializing products for the critical care market, today announced the closing of an underwritten offering for gross proceeds of approximately $10 million, prior to deducting underwriting discounts and co...

Have a Heart Acquires Leading Cannabis Brokerage Company

Cannabis retailer inks deal with CannaMLS, garnering insight into deal flow across the industry Cannabis retailer Have a Heart today announced its acquisition of CannaMLS, a leading cannabis brokerage company, for a

CloudMinds XI™ Smart Raman Selected as a Finalist for Prism Award; Solution to be Featured in Demos at BiOS Booth 8864 and PW Booth 4087

Prism Award recognizes outstanding examples of innovation and thought leadership in photonics research and development CloudMinds Technology, a developer and operator of cloud robotic solutions announced today that its XI™ Smart Raman has been selected as a finalist in the category of sensors and detectors for the Prism Award. The 2...

Armor Correctional Health Services Promotes Dr. Timothy E. Hughes to Chief Medical Officer

Armor Correctional Health Services is pleased to announce that Timothy E. Hughes, M.D. has been promoted to Chief Medical Officer. Previously, Hughes served as Associate Chief Medical Director. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20181211005881/en/


Advertisement
Quick Search
Advertisement
Advertisement

 

News Quicklinks